COST-EFFECTIVENESS OF VILDAGLIPTIN COMPARED TO GENERIC SULPHONYLUREAS ADDED ON TO METFORMIN FROM THE PORTUGUESE SOCIETAL PERSPECTIVE

被引:1
|
作者
Calado, F. [1 ]
Gruenberger, J. B. [2 ]
Silva-nunes, J. [3 ]
Carvalho, D. [4 ]
机构
[1] Novartis, Sintra, Portugal
[2] Novartis, Basel, Switzerland
[3] Curry Cabral Hosp, Lisbon, Portugal
[4] S Joao Hosp, Fac Med, Oporto, Portugal
关键词
D O I
10.1016/j.jval.2012.08.1688
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A501 / A501
页数:1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    Hiligsmann, M.
    Reginster, J. Y.
    VALUE IN HEALTH, 2010, 13 (07) : A309 - A310
  • [32] Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac
    Mladsi, Deirdre
    Ronquest, Naoko
    Odom, Dawn
    Miles, LaStella
    Saag, Kenneth
    CLINICAL THERAPEUTICS, 2016, 37 (11) : 2418 - 2429
  • [33] Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score ® Test from a US Societal Perspective
    Berdunov, Vladislav
    Carter, Gebra Cuyun
    Laws, Ewan
    Luo, Roger
    Russell, Christy A.
    Campbell, Sara
    Abdou, Yara
    Force, Jeremy
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2024, 16 : 471 - 482
  • [34] THE COST-EFFECTIVENESS OF TRASTUZUMAB OVER THE PRODUCT LIFE CYCLE IN PORTUGAL: A DYNAMIC AND SOCIETAL PERSPECTIVE
    Garrison, L.
    Babigumira, J. B.
    Andrade, S.
    VALUE IN HEALTH, 2012, 15 (07) : A425 - A425
  • [35] A cost-effectiveness analysis of surgical care delivery in Eastern Uganda-a societal perspective
    Obieze Nwanna–Nzewunwa
    Esther Agwang
    Melissa Carvalho
    Mary-Margaret Ajiko
    Rasheedat Oke
    Christopher Yoon
    Mohamed M Diab
    Fred Kirya
    Elliot Marseille
    Catherine Juillard
    Rochelle A. Dicker
    BMC Health Services Research, 23
  • [36] A cost-effectiveness analysis of surgical care delivery in Eastern Uganda-a societal perspective
    Nwanna-Nzewunwa, Obieze
    Agwang, Esther
    Carvalho, Melissa
    Ajiko, Mary-Margaret
    Oke, Rasheedat
    Yoon, Christopher
    Diab, Mohamed M.
    Kirya, Fred
    Marseille, Elliot
    Juillard, Catherine
    Dicker, Rochelle A.
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [37] Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective
    Hornberger, John
    Michalopoulos, Steven
    Dai, Minghan
    Andrade, Paula
    Dilla, Tatiana
    Happich, Michael
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 (02): : 63 - 73
  • [38] Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China
    Hou, Xingyun
    Wan, Xu
    Wu, Bin
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [39] COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Hou, X.
    Wan, X.
    Li, Y.
    Ding, Y.
    Wu, B.
    VALUE IN HEALTH, 2019, 22 : S144 - S144
  • [40] COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN BIOLOGIC-EXPERIENCED PATIENTS FROM THE PORTUGUESE PERSPECTIVE
    Laires, P. A.
    Silva, C.
    Esparteiro, J.
    Fonseca, J. E.
    VALUE IN HEALTH, 2019, 22 : S697 - S697